K162961

Substantially Equivalent

LIAISON® VCA IgG and LIAISON® VCA IgG Serum Control Set; LIAISON® EBNA IgG and LIAISON® EBNA IgG Serum Control Set

Applicant: DiaSorin, Inc.
Product code: LSE
Advisory panel: Microbiology
Date received: 2016-10-24
Decision date: 2017-01-05
Decision: Substantially Equivalent
Clearance type: Special
Location: Stillwater, MN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.